Stay updated on Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial page.

Latest updates to the Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial page
- Check2 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces NIH website transition updates and says “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content. The study record itself remains unavailable.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov version as v3.7.1 instead of v3.7.0. The page otherwise remains a 403 error page.SummaryDifference0.2%

- Check44 days agoChange DetectedThe study page now renders a 403 Forbidden error. The page shows a minimal header with a Home button, replacing the previous study details.SummaryDifference20%

- Check65 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, reflecting a backend software update for the page. This change does not modify the study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial page.